BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11486997)

  • 1. Protease crosstalk with integrins: the urokinase receptor paradigm.
    Chapman HA; Wei Y
    Thromb Haemost; 2001 Jul; 86(1):124-9. PubMed ID: 11486997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of urokinase receptor and caveolin in regulation of integrin signaling.
    Chapman HA; Wei Y; Simon DI; Waltz DA
    Thromb Haemost; 1999 Aug; 82(2):291-7. PubMed ID: 10605716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W; Mizukami I; Todd RF; Petty HR
    Cancer Res; 1997 May; 57(9):1682-9. PubMed ID: 9135008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and alpha v beta 5 integrin.
    Franco P; Vocca I; Carriero MV; Alfano D; Cito L; Longanesi-Cattani I; Grieco P; Ossowski L; Stoppelli MP
    J Cell Sci; 2006 Aug; 119(Pt 16):3424-34. PubMed ID: 16882693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T
    BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic identification of lynchpin urokinase plasminogen activator receptor protein interactions associated with epithelial cancer malignancy.
    Saldanha RG; Molloy MP; Bdeir K; Cines DB; Song X; Uitto PM; Weinreb PH; Violette SM; Baker MS
    J Proteome Res; 2007 Mar; 6(3):1016-28. PubMed ID: 17330942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction between urokinase receptor and vitronectin in cell adhesion and signalling.
    Madsen CD; Sidenius N
    Eur J Cell Biol; 2008 Sep; 87(8-9):617-29. PubMed ID: 18353489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule.
    Ragno P
    Cell Mol Life Sci; 2006 May; 63(9):1028-37. PubMed ID: 16465446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and functional interdependence of the urokinase-type plasminogen activator system with integrins.
    Reuning U; Magdolen V; Hapke S; Schmitt M
    Biol Chem; 2003 Aug; 384(8):1119-31. PubMed ID: 12974381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of integrin alpha M beta 2 ligand-binding function by the urokinase-type plasminogen activator receptor.
    Tang ML; Kong LS; Law SK; Tan SM
    Biochem Biophys Res Commun; 2006 Sep; 348(3):1184-93. PubMed ID: 16905120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The urokinase plasminogen activator receptor in the regulation of the actin cytoskeleton and cell motility.
    Kjøller L
    Biol Chem; 2002 Jan; 383(1):5-19. PubMed ID: 11928822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemostatic factors occupy new territory: the role of the urokinase receptor system and kininogen in inflammation.
    Chavakis T; Kanse SM; May AE; Preissner KT
    Biochem Soc Trans; 2002 Apr; 30(2):168-73. PubMed ID: 12023845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
    van der Pluijm G; Sijmons B; Vloedgraven H; van der Bent C; Drijfhout JW; Verheijen J; Quax P; Karperien M; Papapoulos S; Löwik C
    Am J Pathol; 2001 Sep; 159(3):971-82. PubMed ID: 11549590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal regulation of urokinase receptor (CD87)-mediated cell adhesion by plasminogen activator inhibitor-1 and protease nexin-1.
    Kanse SM; Chavakis T; Al-Fakhri N; Hersemeyer K; Monard D; Preissner KT
    J Cell Sci; 2004 Jan; 117(Pt 3):477-85. PubMed ID: 14679304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between hepatocyte growth factor and integrin signaling pathways.
    Chan PC; Chen SY; Chen CH; Chen HC
    J Biomed Sci; 2006 Mar; 13(2):215-23. PubMed ID: 16496226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The urokinase receptor (uPAR) and the uPAR-associated protein (uPARAP/Endo180): membrane proteins engaged in matrix turnover during tissue remodeling.
    Behrendt N
    Biol Chem; 2004 Feb; 385(2):103-36. PubMed ID: 15101555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Physical association of uPAR with the alphaV integrin on the surface of human NK cells.
    Gellert GC; Goldfarb RH; Kitson RP
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1025-32. PubMed ID: 14985115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.
    Binder BR; Mihaly J; Prager GW
    Thromb Haemost; 2007 Mar; 97(3):336-42. PubMed ID: 17334498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of urokinase receptor function and pericellular proteolysis by the integrin alpha(5)beta(1).
    Bass R; Ellis V
    Thromb Haemost; 2009 May; 101(5):954-62. PubMed ID: 19404550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.